U.S. Alzheimer's Disease Medication Market
U.S. Alzheimer's Disease Medication Market
RELEASE DATE
04-Aug-2010
04-Aug-2010
REGION
North America
North America
Research Code: N731-01-00-00-00
SKU: HC02145-NA-MR_07723
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02145-NA-MR_07723
Description
This research service provides an indepth analysis of factors affecting the growth of the U.S. Alzheimer's disease medication market over the period 2006-2016. Following an introduction to the market, which includes segmentation, patient forecasts, and market trends, readers are presented with a detailed examination of therapeutic candidates in Alzheimer's pipeline. Finally, revenue forecasts and market share analyses are presented for existing therapies as well as three new-mechanism drugs with potential to reach the market within the forecast period.
Table of Contents
U.S. Alzheimer's Disease Medication Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Information Update Regarding Eli Lilly’s Discontinuation of semagacestat Clinical Trials
Disease Overview and Patient Forecasts
- Disease Overview
- Diseases Causes and Risk Factors
- Diagnosis
- Patient Forecasts
Market Trends
- Market Engineering Measurements
- Industry Challenges and Strategies
- Market Drivers
Approved Product Overview
Pipeline Analysis by Mechanism of Action
Revenue Forecasts
Competitive Overview
Market Share Analysis
Decision Support Databases
Related Research
Popular Topics
This research service provides an indepth analysis of factors affecting the growth of the U.S. Alzheimer's disease medication market over the period 2006-2016. Following an introduction to the market, which includes segmentation, patient forecasts, and market trends, readers are presented with a detailed examination of therapeutic candidates in Alzheimer's pipeline. Finally, revenue forecasts and market share analyses are presented for existing therapies as well as three new-mechanism drugs with potential to reach the market within the forecast period.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N731-01-00-00-00 |
Is Prebook | No |